TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 DKK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
393
|
472
|
411 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-28
|
11
|
-65 |
| EBITDA |
-28
|
11
|
-65 |
| Total assets |
216
|
224
|
215 |
| Current assets |
216
|
224
|
215 |
| Current liabilities |
75
|
60
|
69 |
| Equity capital |
141
|
165
|
146 |
| - share capital |
68
|
66
|
63 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
65.3%
|
73.7%
|
67.9% |
| Turnover per employee |
393
|
472
|
411 |
| Profit as a percentage of turnover |
-7.1%
|
2.3%
|
-15.8% |
| Return on assets (ROA) |
-13.0%
|
4.9%
|
-30.2% |
| Current ratio |
288.0%
|
373.3%
|
311.6% |
| Return on equity (ROE) |
-19.9%
|
6.7%
|
-44.5% |
| Change turnover |
-91
|
42
|
-95 |
| Change turnover % |
-19%
|
10%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.